Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
John R. Hurst(The Royal Free Hospital), Jadwiga A. Wedzicha(Imperial College London), Hana Müllerová(AstraZeneca (United Kingdom)), Nicholas Locantore(Research Triangle Park Foundation), Ruth Tal‐Singer, Bruce E. Miller, William MacNee(The Queen's Medical Research Institute), Àlvar Agustí(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Emiel F.�M. Wouters(Maastricht University), Stephen I. Rennard(University of Nebraska at Omaha), Jørgen Vestbo(Manchester Academic Health Science Centre), Antonio Anzueto(The University of Texas at San Antonio Health Science Center), David A. Lomas(Institute of Structural and Molecular Biology), Peter M.A. Calverley(University of Liverpool)
Cited by 2,977
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
|American Journal of Respiratory and Critical Care Medicine|2017|3.2k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2015|1.3k